NRC Health boosts CEO Trent Green with $1.9 million tax bonus on equity change

• NRC Health amended equity award agreements on April 27, 2026, removing a $1 repurchase right tied to termination for cause or resignation for good reason before third anniversary of grant date.
• Committee authorized cash bonuses of about $1.9 million for CEO Trent Green, about $0.5 million each for COO Helen Hrdy and Chief Corporate Development Officer Andrew Monich to cover estimated cash taxes tied to changes.
• Changes are expected to drive about $9.4 million of second-quarter 2026 expense, including about $6.5 million of non-cash accelerated equity compensation.
• Company also expects about $2.9 million of cash bonus expense, primarily related to tax payments.
• Acceleration pulls forward expense that otherwise would have been recognized through second-quarter 2028, eliminating future-period impact from these awards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRC - National Research Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-013646), on April 28, 2026, and is solely responsible for the information contained therein.